MIR22HG was decreased obviously in the HCC cell lines including SMMC-7721 (P<0.001), Huh-7 (P<0.001) and Hep3B (P<0.001), compared with the control group of THLE-2 (Figure 1B). This evidence concerns the gene MIR22HG and hepatocellular carcinoma.